Page last updated: 2024-12-08

bispyribac

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bispyribac: acute human self-poisoning with bispyribac-containing herbicide Nominee has been reported; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bispyribac : A member of the class of benzoic acids that is benzoic acid substituted by (4,6-dimethoxypyrimidin-2-yl)oxy groups at positions 2 and 6. Its sodium salt is used as a broad spectrum post emergent herbicide for the control of grasses, sedges and broadleaf weeds in rice crops. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID443031
CHEMBL ID3306579
CHEBI ID3129
SCHEMBL ID65725
MeSH IDM0546068

Synonyms (35)

Synonym
bispyribac
125401-75-4
2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
FT-0651806
A805380
2,6-bis((4,6-dimethoxypyrimidin-2-yl)oxy)benzoic acid
bispyribac [iso:bsi]
unii-9w20bd966g
hsdb 7945
9w20bd966g ,
nanogen index code bpx (3-031)
AKOS016002145
benzoic acid, 2,6-bis[(4,6-dimethoxy-2-pyrimidinyl)oxy]-
AM20020330
bispyribac [iso]
benzoic acid, 2,6-bis((4,6-dimethoxy-2-pyrimidinyl)oxy)-
bispyribac [mi]
bispyribac [hsdb]
SCHEMBL65725
DTXSID0043977
CHEBI:3129 ,
2,6-bis(4,6-dimethoxy-2-pyrimidinyloxy)benzoic acid
2,6-bis[(4,6-dimethoxypyrimidin-2-yl) oxy]benzoic acid
RYVIXQCRCQLFCM-UHFFFAOYSA-N
2,6-bis[(4.6-dimethoxypyrimidin-2-yl)oxy]benzoic acid
CHEMBL3306579
2,6-bis[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzoic acid
6ql ,
mfcd02071313
c19h18n4o8
DS-14855
Q27105948
benzoic acid, 2,6-bis[(4,6-dimethoxy-2-pyrimidinyl)oxy]-; 2,6-bis[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzoic acid; bispyribac
I10550
CS-0012885

Research Excerpts

Overview

Bispyribac sodium (BS) is an herbicide that inhibits the activity of acetolactate synthase. It is widely used for the control of weeds in rice.

ExcerptReferenceRelevance
"Bispyribac-sodium (BIS) is a new broad-spectrum and efficient herbicide, which is widely used for the control of weeds in rice. "( Monoclonal antibody production and development of immunochromatographic strip assays for screening of the herbicide bispyribac-sodium in rice.
Chao, M; Guo, L; Liu, L; Wu, A; Xu, C; Xu, X; Zhou, W, 2023
)
2.56
"Bispyribac sodium (BS) is an herbicide that inhibits the activity of acetolactate synthase."( A novel rice cytochrome P450 gene, CYP72A31, confers tolerance to acetolactate synthase-inhibiting herbicides in rice and Arabidopsis.
Hori, K; Horita, J; Itoh, T; Iwakami, S; Kaku, K; Matsumoto, T; Nishizawa-Yokoi, A; Nonaka, S; Saika, H; Shimizu, T; Taguchi-Shiobara, F; Tanaka, T; Toki, S; Yano, M, 2014
)
1.12
"Bispyribac-sodium is a commonly used herbicide. "( Analysis of the herbicide bispyribac-sodium in rice by solid phase extraction and high performance liquid chromatography.
Mei, J; Wu, S, 2011
)
2.11

Dosage Studied

ExcerptRelevanceReference
" In this study, dose-response of the SU-resistant accession was compared with that of a SU-susceptible accession at in vivo whole-plant level as well as at in vitro enzymatic level."( Characterization of sulfonylurea-resistant Schoenoplectus juncoides having a target-site Asp(376)Glu mutation in the acetolactate synthase.
Ikeda, H; Kizawa, S; Sada, Y; Yamato, S, 2013
)
0.39
" Whole-plant dose-response tests showed that the SX population exhibited 11."( The basis of resistance mechanism to mesosulfuron-methyl in Tausch's goatgrass (Aegilops tauschii Coss.).
Huang, H; Huang, Z; Sui, B; Wei, S; Zhang, C, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
herbicideA substance used to destroy plant pests.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
aromatic etherAny ether in which the oxygen is attached to at least one aryl substituent.
pyrimidinesAny compound having a pyrimidine as part of its structure.
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (2.56)29.6817
2010's29 (74.36)24.3611
2020's9 (23.08)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.90 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index5.49 (4.65)
Search Engine Demand Index105.18 (26.88)
Search Engine Supply Index3.35 (0.95)

This Compound (43.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other40 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]